Login
Home / RLYB : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Rallybio Corporation

$16.84 +$11.18 (+197.53%)
NASDAQ · 14 Sep 2026 16:30 UTC
Previous Close
$16.88
Day Range
$16.7$17.03
Year Range
$3.67$17.57
Market Cap
89.37M
AVG Volume
69.68K
Trailing/Forward PE
2.12/-
PEG ratio
0.02
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD)
0100K200K300K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD)
-20M020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD)
-20M-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD)
-20M020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD)
-20M020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (USD)
-5051024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD)
05M10M15M20MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (USD)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-4-20224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
-3000%-2000%-1000%0%1000%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q1
Return on Capital
-40%-20%0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Book Value Per Share (USD)
0510152024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (USD)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Employee Count
020406020212022202320242025
PE Ratio
22.052.12.15med 2.11Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
Free Cash Flow Yield
-600%-400%-200%0%200%med -121.26%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
050100150200med 50.62Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
-0.0500.050.10.15med 0.12Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
Price/Operating Cashflow
3.453.53.553.63.653.7med 3.65Aug 26Aug 26Aug 26Aug 26Sep 26Sep 26
Price to Book
00.511.52med 0.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Rallybio Corporation
RLYB
Stockpicker

Video analysis: RLYB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RLYB

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

gurufocus.com · 21 Jul 2026

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026
Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

prnewswire.com · 21 Jul 2026

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.